MedTrace Logo

Satisfaction With XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma

NCT03852810 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2021-10-20

No results posted yet for this study

Summary

This is a prospective, observational, non-interventional study of patients scheduled to receive surgical intervention either via XEN or trabeculectomy for open-angle glaucoma. The decision to treat patients with a particular surgical procedure will not be influenced by the study as the treatment decision will continue to be made by the patient and the clinician. There will be no study mandated visits or treatments.

Conditions

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Joanna Campbell, Ph.D · Allergan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2020-12-09
Completion
2020-12-09

Countries

  • Canada
  • Germany
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03852810 on ClinicalTrials.gov